About Us
Overview
Mission and Vision
Board of Directors
Recognitions
Business Areas
Overview
India - Branded Generics
Emerging Markets - Branded Generics
USA - Generics
Africa - Institution Business
Manufacturing
Overview
Manufacturing facilities
Quality
Environment, Health & Safety
R & D
Investors
Financials
Corporate Governance
Investor Information
Media
Press release
Media Covarage
Media Kit
Career
Life at Ajanta
Work with us
CSR
Contact Us
Search
investor information
Home
Investors
Investor Information
Statutory Communications
Year
2024-25
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
Intimation of Board Meeting Q3 2018 & Trading Window Closure
Intimation of Board Meeting Q2 2018 & Trading Window Closure
US FDA Inspection of our Dahej Facility in Feb 2018
Notice of Board meeting and closure of Trading Window
Newspaper ad for NCLT convened meeting
Intimation of Board Meeting Q1 2018 & Trading Window Closure
Press Release - Promoters sell small stake in Ajanta Pharma
1
2
>
Related Links
Statutory Communications
Unclaimed Dividend
Unclaimed Shares
Investor Contact
Smart ODR & KYC form
FAQs
Buyback
Miscellaneous
